Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of Epigenetic Plasticity in PDAC
$468,246Chunling Yi · Georgetown University · R01 · FY2024 · CA
Exosome secretion in breast cancer progression
$468,221Alissa M Weaver · Vanderbilt University · R01 · FY2021 · CA
Targeting UHRF1 in combinational immunotherapy
$468,148Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
Investigating the Immunosuppressive Function of lncRNA CRNDE in Hepatic Tumorigenesis
$468,139Jinqiang Zhang · Tulane University Of Louisiana · R01 · FY2025 · CA
Targeting the innate immune response in HNSCC
$468,023Judith A. Varner · University Of California, San Diego · R01 · FY2017 · DE
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
$467,974Chin-Tu Chen · University Of Chicago · R01 · FY2024 · CA
Normalizing Breast Cancer Metabolism to Prevent Progression and Recurrence (PQ21)
$467,930Brunhilde Felding-Habermann · Scripps Research Institute, The · R01 · FY2015 · CA
Normalizing Breast Cancer Metabolism to Prevent Progression and Recurrence (PQ21)
$467,930Brunhilde Felding-Habermann · Scripps Research Institute, The · R01 · FY2012 · CA
Metaplastic Tuft Cells in Pancreatic Cancer
$467,825Howard C Crawford · Henry Ford Health System · R01 · FY2021 · CA
Project 1: Molecular Determinants of GIST Pathogenesis
$467,815Ping Chi · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2016 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2020 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2018 · CA
Regulation of Tumor Metastasis by E-Cadherin Activation and Hippo Signaling
$467,754Barry M Gumbiner · Seattle Children'S Hospital · R01 · FY2017 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$467,748Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2018 · CA
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
$467,603Mark David Pagel · University Of Arizona · R01 · FY2012 · CA
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
$467,592Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$467,591Haifa Shen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Deciphering the Roles of STING-Mediated T cell Pyroptosis in Antitumor Immunity
$467,502Jianjun Wu · Cleveland Clinic Lerner Com-Cwru · R37 · FY2025 · CA
Deciphering the Roles of STING-Mediated T cell Pyroptosis in Antitumor Immunity
$467,502Jianjun Wu · Cleveland Clinic Lerner Com-Cwru · R37 · FY2024 · CA
Development of a preclinical optical frequency domain angiography instrument
$467,429Benjamin James Vakoc · Massachusetts General Hospital · R01 · FY2014 · CA
Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
$467,420Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$467,360Paul Mathew · Tufts Medical Center · R01 · FY2022 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$467,258Xiaoqi Liu · University Of Kentucky · R01 · FY2021 · CA
IMPROVING BREAST CANCER VACCINE THERAPY VEIA NORMALIZATION OF TUMOR VASCULATURE AND MICROENVIRONMENT
$467,256The General Hospital Corporation · · FY2011 · Department of Defense